1. Abele, R., Aapro, M. S., Haefliger, J-M. and Alberto, P., Phase I Study of Cyclophosphamide and Lysine Salt of Mafosfamide.Cancer Chemo. Pharmaco., 16, 182–183 (1986).
2. Aiko, I., Owari, S. and Torigoe, M., Nitrogen mustard N-oxide and its effects on the Yoshida sarcoma.J. Pharm. Soc. (Japan), 72, 1297–1300 (1952).
3. Alberts, D. S., Einspahr, J. G., Struck, R. F., Bignami, G., Young, L., Surwit, E. A. and Salmon, S. E., Comparative in vitro cytotoxicity of cyclophosphamide, its major active metabolites and the new oxazaphosphorine ASTA Z 7557 (INN mafosfamide).Inv. New Drugs, 2, 141–148 (1984).
4. Anders, M. W., Ratnayake, J. H., Hanna, P. E. and Fuchs, J. A., Involvement of thioredoxin in sulfoxide reduction by mammalian tissues.Biochem. & Biophys. Res. Comm., 97 (3), 846–851 (1980).
5. Aymard, C., Seyer, L. and Cheftel, J., Enzymatic reduction of methionine sulfoxide. In vitro experiments with rat liver and kidney.Agric. Biol. Chem., 43, 1869–1872 (1979).